Bharat Biotech

New Delhi:  Hyderabad-based vaccine manufacturer Bharat Biotech on Friday announced that its whole-virion inactivated Covid vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in paediatric subjects in phase II/III…

New Delhi:  Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population. According to a source, Bharat Biotech has sought approval from…

New Delhi:  The National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 year age group, sources said. India's drug regulator, the Drugs Controller…

New Delhi: Hyderabad-based vaccine manufacturer Bharat Biotech on Friday announced the temporary slowing down of its Covid vaccine Covaxin's production across its manufacturing facilities. "Bharat Biotech today announces the temporary…

Hyderabad:  Vaccine maker Bharat Biotech on Wednesday announced partnership with Spanish biopharmaceutical company Biofabri to develop, manufacture and market a new tuberculosis vaccine in more than 70 countries in Southeast Asia and…

New Delhi: In a major development on Friday, the Drugs Controller General of India (DCGI) allowed Hyderabad-based vaccine manufacturer Bharat Biotech to conduct clinical trials for its intranasal Covid booster dose in India. The clinical…

Hyderabad: Vaccine maker Bharat Biotech on Wednesday clarified that Paracetamol or pain killers are not recommended for teenagers after being vaccinated with Covaxin. "We have received feedback that certain immunisation centres are…

New Delhi:  The vaccination for children aged between 15 and 18 began amid a surge in Covid-19 infections on Monday. Over 16 lakh teens have been vaccinated so far on the first day of vaccination, as per the government's CoWin portal.…

New Delhi:  Amid rising Omicron cases, the Centre on Monday rolled out Covid vaccination for children aged 15-18. Over 4.5 lakh teenagers have, received their first jab against the infectious disease so far. Last week, Prime Minister…

Hyderabad:  Bharat Biotech is targeting to make one billion doses of its Covid-19 intranasal vaccine annually while it is on track to achieve one billion doses of Covaxin, India's first indigenous Covid vaccine. The Hyderabad-based…